
Many studies have assessed the benefits of nutrition support in cancer zzso Except for studies directed at the treatment of severe zzso most clinical trials have zzso Although prospective zzso controlled clinical trials zzso zzso remain the most reliable means of evaluating the efficacy of therapy, the available literature reports only results from small trials zzso II to zzso most of which appear to be contradictory and none of which zzso answer the question being zzso To address this gap in knowledge, tools such as zzso have been adapted from the field of zzso zzso involves pooling results across several studies and provides a more precise estimate of treatment effect than can each individual zzso However, clinical trials selected for zzso although broadly similar, can differ significantly in terms of therapies used and clinical populations zzso Major cancer types with differing effects on food intake and zzso zzso the mechanical obstruction in head and neck cancer vs the zzso zzso associated with zzso zzso zzso and breast zzso cannot be subject to the same zzso zzso In this paper, the current state of clinical outcome trials in nutrition and cancer is zzso and the desired design for future studies is zzso Research priorities include the conduct of Phase II clinical trials that use as outcome measures quality of life, performance status, and survival to identify optimal zzso and zzso nutrition zzso The next round of Phase III efficacy studies should establish the appropriate use of nutrition support in cancer zzso 

